Faulkingham Dell's Form 4 filing
Akebia Therapeutics, Inc. (AKBA) · filed Mar 2, 2022
- Accession no.
- 0001562180-22-002162
- Filed
- Mar 2, 2022
- Trade date
- Feb 28-Mar 1, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 4 non-derivative transactions and 1 derivative transaction. Open-market sales total $28.5K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Faulkingham DellCIK 0001776024 | Officer (SVP, CCO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 28, 2022 | Common Stock | SSaleDisposed | −6,479 | $2.15 | −$13,929.85 | 130,546 | Direct | |
| Feb 28, 2022 | Common Stock | AGrant or awardAcquired | +50,000 | $0.00 | $0 | 180,546 | Direct | |
| Mar 1, 2022 | Common Stock | SSaleDisposed | −5,748 | $2.17 | −$12,473.16 | 174,798 | Direct | |
| Mar 1, 2022 | Common Stock | SSaleDisposed | −957 | $2.17 | −$2,076.69 | 173,841 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 28, 2022 | Common Stock | AGrant or awardAcquired | +200,000 | $0.00 | $0 | 200,000 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.